Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

CRISPR Therapeutics AG (CRSP)

NASDAQ

$52,42

$+0,52

(+1,00%)

Pre-Market

CRISPR Therapeutics AG (CRSP) Live Price Chart

Last updated: ⁦2026-09-16 09:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

CRISPR Therapeutics AG (CRSP) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $52,42, with a market capitalisation of $5,12B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $44,12 to $78,48. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5,12B
Open	$51,90
Day's High	$220,20
Day's Low	$11,63
Previous Close	$51,83
Volume	2,67K
Average Volume	1,56M
P/E Ratio	--
52-Week High	$78,48
52-Week Low	$44,12
Dividend Yield	--
Earnings Date	--

CRISPR Therapeutics AG (CRSP) Pre-Market Stock Price

CRISPR Therapeutics AG (CRSP) is trading at $52,42 in pre-market trading as of 2026-09-16 08:55:00, up 1,14% ($0,59) from the previous close of $51,83

Pre-market trading shows how investors are pricing CRSP before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

CRISPR Therapeutics AG (CRSP) 7-Day Stock Price Change

Over the past seven days, CRISPR Therapeutics AG (CRSP) moved from $55,79 to $52,42, representing a decline of 6,04% ($3,37).

The stock traded between $51,33 and $57,21 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1,20 million shares, up versus the previous seven-day period, indicating higher trading activity.

CRSP 52-Week Price Position

Position in Range: 24,2%

52W Low$44,12

52W High$78,48

CRSP is currently trading at $52,42, placing it 24,2% of the way from its 52-week low of $44,12 to its 52-week high of $78,48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is CRISPR Therapeutics AG (CRSP)?

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

CRISPR Therapeutics AG Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	393
Exchange	NASDAQ
Company Website	https://www.crisprtx.com

How to Buy CRISPR Therapeutics AG (CRSP) Stock on MEXC

Eligible investors can buy real shares of CRISPR Therapeutics AG (CRSP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRSP and Place Your Order

Open the RealStocks trading page and search for CRSP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is CRISPR Therapeutics AG (CRSP) stock price today?

CRISPR Therapeutics AG (CRSP) is currently trading at $ 52,42, up 1,14% ($0,59) from the previous close of $ 51,83. Intraday prices update in real time during regular trading hours.

2.Is CRSP stock going up or down today?

As of 2026-09-16 08:55:00, CRSP is trading at $ 52,42, up 1,14% ($0,59) from its previous close of $ 51,83. The stock has traded between $ 11,63 and $ 220,20 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRSP pre-market price?

As of 2026-09-16 08:55:00, CRSP is trading at $ 52,42 in pre-market trading, up 1,14% ($0,59) from the previous close of $ 51,83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRSP after-hours price?

As of 2026-09-16 08:55:00, CRSP is trading at $ 51,90 in after-hours trading, up 0,14% ($0,07) from the regular-session close of $ 51,83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRSP stock trading now?

CRSP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRSP sit relative to its 52-week high and low?

Over the past 52 weeks, CRSP has traded between a low of $ 44,12 and a high of $ 78,48. At $ 52,42, the stock is positioned 24,2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is CRISPR Therapeutics AG in?

CRISPR Therapeutics AG (CRSP) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is CRISPR Therapeutics AG's market capitalisation and where is it listed?

CRISPR Therapeutics AG is listed on the NASDAQ exchange with a market capitalisation of $ 5,12B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRSP valued in terms of P/E ratio and EPS?

CRSP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4,67. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does CRISPR Therapeutics AG pay a dividend?

CRISPR Therapeutics AG pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.